German Breast group
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
2014 · Patricia Cortazar, Lijun Zhang, et al. · The Lancet
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
2014 · Roberto Salgado, Carsten Denkert, et al. · Annals of Oncology
Trastuzumab Emtansine for Residual Invasive HER2-Positive Breast Cancer
2018 · Gϋnter von Minckwitz, Chiun‐Sheng Huang, et al. · New England Journal of Medicine